Patients with schizophrenia who receive a long-acting injectable (LAI) formulation as the first anti...
Patients with a recent first episode of schizophrenia who are treated with a long-acting injectable ...
A three-month formulation of paliperidone palmitate administered four times yearly as a long-acting ...
